This menu provides the list of EV miRNAs identified by high-throughput analyses.
Refresh all contents
Search:
Dataset accession
miRBase accession
Mature name
Orthologous group
Superdomain:
All
Prokaryote
Eukaryote
Filter datasets:
- "Sample type" indicates the source from which EVs originated (e.g. B cell, serum).
- "Sample status" indicates the condition of the source from which EVs originated (e.g. Normal, miR-146a-treated, Patients of hernia).
By species
Homo sapiens
Mus musculus
Rattus norvegicus
In vitro/In vivo
Ex vivo
In vitro
In vivo
By sample type
Adipocyte (3T3-L1)
B cell (Raji)
Blood
Breast cancer cell (MCF7)
Colon cancer cell (HCT116)
Colon cancer cell (HT29)
Colon cancer cell (RKO)
Colon cancer cell (SW48)
Colon cancer cell (SW480)
Colorectal cancer cell (SW480)
Fetal human colon epithelial cell (FHC)
Gastric cancer cells (SGC-7901)
Liver cancer cells (CSQT-2)
Liver cancer cells (HCC-LM3)
Liver cancer cells (HepG2)
Liver cancer cells (MHCC-97L)
Lung cancer cell (SBC-3)
Lung cancer cells (A549)
Mast cell (HMC-1)
Oral cancer cells (HOC313-LM)
Oral cancer cells (HOC313-P)
Pancreatic cancer cells (AsPC1, BxPC3, Capan1, Capan2, MiaPaca2, Panc1, Pt45P1, A818, Colo357, HD3577)
Pancreatic cancer cells (KPC)
Pancreatic ductal epithelial cells (MPDC)
Primary dendritic cell
Saliva
Serum
T cell (Jurkat)
By sample status
Cisplatin-resistant
Colorectal cancer_stage1
Colorectal cancer_stage1_after_resection
Colorectal cancer_stage2
Colorectal cancer_stage2_after_resection
Colorectal cancer_stage3a
Colorectal cancer_stage3a_after_resection
Colorectal cancer_stage3b
Colorectal cancer_stage3b_after_resection
Colorectal cancer_stage4
Colorectal cancer_stage4_after_resection
Day 2-4 after differentiation into adipocytes
Day 8-10 after differentiation into adipocytes
Extremely severe hand, foot, and mouth disease
Healthy_timepoint1
Healthy_timepoint2
Mild hand, foot, and mouth disease
Normal
Normal_Agilent
Normal_Exiqon
Omeprazole-treated
Oral lichen planus patient
Pancreatic cancer patient_Agilent
Pancreatic cancer patient_Exiqon
Pollen allergy_timepoint1
Pollen allergy_timepoint2
Reflux esophagitis
Maximum false positive rate (FPR):
Maximum true positive rate (TPR):
- FPR is the probability that an absent miRNA accidently have higher intensity than that miRNA.
- TPR is the percentile of miRNA among the present miRNAs.
Please see user manual in the contact us/help menu for detail.
Number of molecules in one page:
100
200
All
The downloaded CSV file is not exactly the same as the displayed table. Opening CSV file with Excel can impair its content.
Since there are multiple primers in the microarray, the same miRNA can have several FPR and TPR values.
Mature name
miRBase accession
FPR
TPR
Publication
Orthologous group
Identification count
All / Prokaryote / Eukaryote
(FPR<0.05,TPR<0.5)
rno-miR-483-5p
MIMAT0017201
0.0e+0
4.4e-1
Expression of Serum Exosomal and Esophageal MicroRNA in Rat Reflux Esophagitis.
Int J Mol Sci. 2017 Jul 25;18(8). pii: E1611. doi: 10.3390/ijms18081611.
MIPF0000180_1
54
/
0
/
54
rno-miR-483-5p
MIMAT0017201
0.0e+0
4.4e-1
Expression of Serum Exosomal and Esophageal MicroRNA in Rat Reflux Esophagitis.
Int J Mol Sci. 2017 Jul 25;18(8). pii: E1611. doi: 10.3390/ijms18081611.
MIPF0000180_1
54
/
0
/
54
rno-miR-483-5p
MIMAT0017201
0.0e+0
3.9e-1
Expression of Serum Exosomal and Esophageal MicroRNA in Rat Reflux Esophagitis.
Int J Mol Sci. 2017 Jul 25;18(8). pii: E1611. doi: 10.3390/ijms18081611.
MIPF0000180_1
54
/
0
/
54
rno-miR-483-5p
MIMAT0017201
0.0e+0
3.7e-1
Expression of Serum Exosomal and Esophageal MicroRNA in Rat Reflux Esophagitis.
Int J Mol Sci. 2017 Jul 25;18(8). pii: E1611. doi: 10.3390/ijms18081611.
MIPF0000180_1
54
/
0
/
54
rno-miR-483-5p
MIMAT0017201
0.0e+0
4.2e-1
Expression of Serum Exosomal and Esophageal MicroRNA in Rat Reflux Esophagitis.
Int J Mol Sci. 2017 Jul 25;18(8). pii: E1611. doi: 10.3390/ijms18081611.
MIPF0000180_1
54
/
0
/
54
rno-miR-483-5p
MIMAT0017201
0.0e+0
4.5e-1
Expression of Serum Exosomal and Esophageal MicroRNA in Rat Reflux Esophagitis.
Int J Mol Sci. 2017 Jul 25;18(8). pii: E1611. doi: 10.3390/ijms18081611.
MIPF0000180_1
54
/
0
/
54
rno-miR-483-5p
MIMAT0017201
0.0e+0
4.6e-1
Expression of Serum Exosomal and Esophageal MicroRNA in Rat Reflux Esophagitis.
Int J Mol Sci. 2017 Jul 25;18(8). pii: E1611. doi: 10.3390/ijms18081611.
MIPF0000180_1
54
/
0
/
54
rno-miR-483-5p
MIMAT0017201
0.0e+0
3.8e-1
Expression of Serum Exosomal and Esophageal MicroRNA in Rat Reflux Esophagitis.
Int J Mol Sci. 2017 Jul 25;18(8). pii: E1611. doi: 10.3390/ijms18081611.
MIPF0000180_1
54
/
0
/
54
rno-miR-483-5p
MIMAT0017201
0.0e+0
4.9e-1
Expression of Serum Exosomal and Esophageal MicroRNA in Rat Reflux Esophagitis.
Int J Mol Sci. 2017 Jul 25;18(8). pii: E1611. doi: 10.3390/ijms18081611.
MIPF0000180_1
54
/
0
/
54
rno-miR-483-5p
MIMAT0017201
0.0e+0
4.2e-1
Expression of Serum Exosomal and Esophageal MicroRNA in Rat Reflux Esophagitis.
Int J Mol Sci. 2017 Jul 25;18(8). pii: E1611. doi: 10.3390/ijms18081611.
MIPF0000180_1
54
/
0
/
54
rno-miR-483-5p
MIMAT0017201
0.0e+0
4.3e-1
Expression of Serum Exosomal and Esophageal MicroRNA in Rat Reflux Esophagitis.
Int J Mol Sci. 2017 Jul 25;18(8). pii: E1611. doi: 10.3390/ijms18081611.
MIPF0000180_1
54
/
0
/
54
rno-miR-483-5p
MIMAT0017201
0.0e+0
3.6e-1
Expression of Serum Exosomal and Esophageal MicroRNA in Rat Reflux Esophagitis.
Int J Mol Sci. 2017 Jul 25;18(8). pii: E1611. doi: 10.3390/ijms18081611.
MIPF0000180_1
54
/
0
/
54
rno-miR-483-5p
MIMAT0017201
0.0e+0
4.4e-1
Expression of Serum Exosomal and Esophageal MicroRNA in Rat Reflux Esophagitis.
Int J Mol Sci. 2017 Jul 25;18(8). pii: E1611. doi: 10.3390/ijms18081611.
MIPF0000180_1
54
/
0
/
54
hsa-miR-483-5p
MIMAT0004761
0.0e+0
4.7e-1
Tumor microenvironment interruption: a novel anti-cancer mechanism of Proton-pump inhibitor in gastric cancer by suppressing the release of microRNA-carrying exosomes.
Am J Cancer Res. 2017 Sep 1;7(9):1913-1925. eCollection 2017.
MIPF0000180_1
54
/
0
/
54
hsa-miR-483-5p
MIMAT0004761
0.0e+0
4.3e-1
Tumor microenvironment interruption: a novel anti-cancer mechanism of Proton-pump inhibitor in gastric cancer by suppressing the release of microRNA-carrying exosomes.
Am J Cancer Res. 2017 Sep 1;7(9):1913-1925. eCollection 2017.
MIPF0000180_1
54
/
0
/
54
hsa-miR-483-5p
MIMAT0004761
0.0e+0
4.3e-1
Tumor microenvironment interruption: a novel anti-cancer mechanism of Proton-pump inhibitor in gastric cancer by suppressing the release of microRNA-carrying exosomes.
Am J Cancer Res. 2017 Sep 1;7(9):1913-1925. eCollection 2017.
MIPF0000180_1
54
/
0
/
54
hsa-miR-483-5p
MIMAT0004761
0.0e+0
4.1e-1
Tumor microenvironment interruption: a novel anti-cancer mechanism of Proton-pump inhibitor in gastric cancer by suppressing the release of microRNA-carrying exosomes.
Am J Cancer Res. 2017 Sep 1;7(9):1913-1925. eCollection 2017.
MIPF0000180_1
54
/
0
/
54
hsa-miR-483-5p
MIMAT0004761
0.0e+0
1.0e-1
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.
MIPF0000180_1
54
/
0
/
54
hsa-miR-483-5p
MIMAT0004761
0.0e+0
1.1e-1
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.
MIPF0000180_1
54
/
0
/
54
hsa-miR-483-5p
MIMAT0004761
3.2e-3
3.2e-3
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.
MIPF0000180_1
54
/
0
/
54
hsa-miR-483-5p
MIMAT0004761
4.2e-3
4.2e-3
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.
MIPF0000180_1
54
/
0
/
54
<
[5]